Research ArticleArticle
Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study
Muna Saleh, Carl Turesson, Martin Englund, Peter A. Merkel and Aladdin J. Mohammad
The Journal of Rheumatology June 2016, jrheum.151033; DOI: https://doi.org/10.3899/jrheum.151033
Muna Saleh
From the Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital, Helsingborg; Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; Department of Clinical Sciences, Orthopaedics and Department of Clinical Sciences Lund, Rheumatology, Lund, Sweden; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK. Supported by research grants from the Faculty of Medicine, Lund University, Governmental Funding of Clinical Research within the Swedish National Health Service, and the Swedish Rheumatism Association (Reumatikerförbundet). M. Saleh, MD, Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital; C. Turesson, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; M. Englund, MD, PhD, Department of Clinical Sciences, Orthopaedics, Lund University, and the Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; A.J. Mohammad, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Rheumatology, Lund, and the Vasculitis and Lupus Clinic, Addenbrooke’s Hospital. Address correspondence to Dr. A.J. Mohammad, Department of Rheumatology, Skåne University Hospital, SE-221 85 Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication April 12, 2016.
Carl Turesson
From the Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital, Helsingborg; Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; Department of Clinical Sciences, Orthopaedics and Department of Clinical Sciences Lund, Rheumatology, Lund, Sweden; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK. Supported by research grants from the Faculty of Medicine, Lund University, Governmental Funding of Clinical Research within the Swedish National Health Service, and the Swedish Rheumatism Association (Reumatikerförbundet). M. Saleh, MD, Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital; C. Turesson, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; M. Englund, MD, PhD, Department of Clinical Sciences, Orthopaedics, Lund University, and the Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; A.J. Mohammad, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Rheumatology, Lund, and the Vasculitis and Lupus Clinic, Addenbrooke’s Hospital. Address correspondence to Dr. A.J. Mohammad, Department of Rheumatology, Skåne University Hospital, SE-221 85 Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication April 12, 2016.
Martin Englund
From the Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital, Helsingborg; Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; Department of Clinical Sciences, Orthopaedics and Department of Clinical Sciences Lund, Rheumatology, Lund, Sweden; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK. Supported by research grants from the Faculty of Medicine, Lund University, Governmental Funding of Clinical Research within the Swedish National Health Service, and the Swedish Rheumatism Association (Reumatikerförbundet). M. Saleh, MD, Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital; C. Turesson, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; M. Englund, MD, PhD, Department of Clinical Sciences, Orthopaedics, Lund University, and the Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; A.J. Mohammad, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Rheumatology, Lund, and the Vasculitis and Lupus Clinic, Addenbrooke’s Hospital. Address correspondence to Dr. A.J. Mohammad, Department of Rheumatology, Skåne University Hospital, SE-221 85 Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication April 12, 2016.
Peter A. Merkel
From the Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital, Helsingborg; Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; Department of Clinical Sciences, Orthopaedics and Department of Clinical Sciences Lund, Rheumatology, Lund, Sweden; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK. Supported by research grants from the Faculty of Medicine, Lund University, Governmental Funding of Clinical Research within the Swedish National Health Service, and the Swedish Rheumatism Association (Reumatikerförbundet). M. Saleh, MD, Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital; C. Turesson, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; M. Englund, MD, PhD, Department of Clinical Sciences, Orthopaedics, Lund University, and the Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; A.J. Mohammad, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Rheumatology, Lund, and the Vasculitis and Lupus Clinic, Addenbrooke’s Hospital. Address correspondence to Dr. A.J. Mohammad, Department of Rheumatology, Skåne University Hospital, SE-221 85 Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication April 12, 2016.
Aladdin J. Mohammad
From the Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital, Helsingborg; Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; Department of Clinical Sciences, Orthopaedics and Department of Clinical Sciences Lund, Rheumatology, Lund, Sweden; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK. Supported by research grants from the Faculty of Medicine, Lund University, Governmental Funding of Clinical Research within the Swedish National Health Service, and the Swedish Rheumatism Association (Reumatikerförbundet). M. Saleh, MD, Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital; C. Turesson, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; M. Englund, MD, PhD, Department of Clinical Sciences, Orthopaedics, Lund University, and the Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; A.J. Mohammad, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Rheumatology, Lund, and the Vasculitis and Lupus Clinic, Addenbrooke’s Hospital. Address correspondence to Dr. A.J. Mohammad, Department of Rheumatology, Skåne University Hospital, SE-221 85 Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication April 12, 2016.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study
Muna Saleh, Carl Turesson, Martin Englund, Peter A. Merkel, Aladdin J. Mohammad
The Journal of Rheumatology Jun 2016, jrheum.151033; DOI: 10.3899/jrheum.151033